Dartmouth-Hitchcock CEO Weinstein to Retire
Dr. James N. Weinstein, CEO and President of Dartmouth-Hitchcock (D-H) and the Dartmouth-Hitchcock Health (D-HH) system, will retire from that position at the end of his term, June 30, 2017, Anne-Lee Verville, Dartmouth-Hitchcock Boards Chair, announced today.
Dr. Weinstein, who first shared his retirement decision with Board leadership in 2015, will remain in the role of CEO and President through the end of his contract, after which he will also carry on his national work with the High Value Healthcare Collaborative, the National Academy of Medicine Board for Population Health, the VA Special Medical Advisory Group, and other bodies on which he serves. He will remain as Peggy Y. Thomson Chair in the Evaluative Clinical Sciences at the Geisel School of Medicine and will continue to hold his academic and clinical positions in the D-H and Geisel Departments of Orthopaedics.
Read the full news release at http://www.dartmouth-hitchcock.org/news/article/47212